ICT Media

ICT investment trends in pharmaceuticals ; Enterprise ICT spending patterns through to the end of 2016

  • KAB359530
  • 83 Pages
  • November 2015
  • ICT Media
Summary
The pharmaceutical industry is in the midst of fundamental changes, brought on by the increasing concerns over the expiry of patents, weak product pipelines, and competition from generics. However, increasing prosperity in emerging markets is creating new avenues for pharmaceutical companies to increase their top-line growth. Thus, to meet the challenges and exploit the opportunities, pharmaceutical companies are increasingly looking towards advanced technologies to stay ahead of the intense competition in the field.

Key Findings
To offset declining sales from the patent cliff, companies are expanding into emerging markets in order to increase their market share, which is in turn leading to increasing investments in their core ICT categories of hardware, software, and IT services.

Kable expects mobility and cloud computing to gain momentum in the next two years, and companies are set to increase spending on these advance technologies in order to enhance their competitiveness.

Meanwhile, pharmaceutical companies are prioritizing their ICT investments relating to clinical and pre-clinical research to drive future RandD requirements.

Synopsis
ICT investment trends in pharmaceuticals presents the findings from a survey of 95 pharmaceutical companies regarding their Information and Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.

The report illustrates the core technologies banks are investing in, including business intelligence, mobility and cloud computing. Understand the approach adopted by pharmaceutical companies to purchase technology and get a better insight into ICT vendors and services providers when pitching their solutions to pharmaceutical companies. The report also focuses on pharmaceutical companies ICT spending trends for specific business systems, identifying the top three IT projects, and understanding the business challenges faced by companies.

In particular, it provides an in-depth analysis of the following:

How ICT budgets are set to change in 2015 in terms of their overall size

Allocation across the core elements of IT spend, including hardware, software, services, communications, and consulting

Distribution of ICT money in areas such as the networks, applications, service desk, and data centers

Which ICT functions pharmaceutical companies are interested in outsourcing

Pharmaceuticals investment priorities based on their budget allocations across core technology categories such as business intelligence, mobility, and cloud computing

Factors that are influencing pharmaceutical companies investments in each technology category

How pharmaceutical companies IT budgets are currently allocated across various segments within a technology category

Pharmaceutical companies distribution of their ICT budget across various segments within a technology category

Vendor satisfaction ratings for various core and advanced technology categories

Insight into pharmaceutical companies preferred buying approaches

Business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies

Factors that are influencing pharmaceutical companies decisions to select an ICT provider

ReasonsToBuy
Understand how the pharmaceutical companies ICT landscape is set to change in 2015 to prioritize your target market

Comprehend how ICT money are being allocated by pharmaceutical companies in specific geographies and size bands to improve your market penetration

Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting)

Realign your sales initiatives by understanding the current strategic objectives of pharmaceutical companies

Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (business intelligence, mobility, and cloud computing)

Prioritize your focus areas by understanding which factors are influencing pharmaceutical companies decisions when selecting an ICT provider

Understand the changes in customers priorities and identify the business and IT objectives that pharmaceutical companies are looking to achieve through their ICT investment strategies
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Telematics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Telematics by the synonym itself defines the integration of telecommunications and information and communications technologies abruptly called as informatics. It can be simply the technology of transmitting, receiving, sending and ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bernfield and colleagues ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Drug Testing Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Tissue Engineering and Regeneration Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Tissue engineering is developed from the field of biomaterials development and refers to the practice of combining cells or tissues with biologically active molecules into functional tissues. They are mainly ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Biopsy Devises Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

2017 © Copyright Big Market Research

View Pricing >>